These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11100992

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Novel agents for the control of secretory diarrhoea.
    Farthing MJ.
    Expert Opin Investig Drugs; 2004 Jul; 13(7):777-85. PubMed ID: 15212618
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antisecretory drugs for diarrheal disease.
    Farthing MJ.
    Dig Dis; 2006 Jul; 24(1-2):47-58. PubMed ID: 16699263
    [Abstract] [Full Text] [Related]

  • 5. Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins.
    Rabbani GH.
    Dan Med Bull; 1996 Apr; 43(2):173-85. PubMed ID: 8741209
    [Abstract] [Full Text] [Related]

  • 6. Novel targets for the control of secretory diarrhoea.
    Farthing MJ.
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III15-8. PubMed ID: 11953327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diarrhoea in children in Papua New Guinea.
    Vince JD.
    P N G Med J; 1995 Dec; 38(4):262-71. PubMed ID: 9522866
    [Abstract] [Full Text] [Related]

  • 12. Antidiarrhoeal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhoea in mice: mechanisms of action.
    Theodorou V, Chovet M, Eutamene H, Fargeau H, Dassaud M, Toulouse M, Bihoreau C, Roman FJ, Bueno L.
    Gut; 2002 Oct; 51(4):522-8. PubMed ID: 12235074
    [Abstract] [Full Text] [Related]

  • 13. Pharmacoeconomics of the therapy of diarrhoeal disease.
    Nathavitharana KA, Booth IW.
    Pharmacoeconomics; 1992 Oct; 2(4):305-23. PubMed ID: 10150156
    [Abstract] [Full Text] [Related]

  • 14. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M, Vidal R, del Canto F, Salazar JC, Montero D.
    Hum Vaccin Immunother; 2015 Oct; 11(3):584-600. PubMed ID: 25715048
    [Abstract] [Full Text] [Related]

  • 15. Enteric nerves and diarrhoea.
    Lundgren O.
    Pharmacol Toxicol; 2002 Mar; 90(3):109-20. PubMed ID: 12071331
    [Abstract] [Full Text] [Related]

  • 16. Antidiarrhoeal agents. Clinical pharmacology and therapeutic use.
    Bradshaw MJ, Harvey RF.
    Drugs; 1982 Nov; 24(5):440-51. PubMed ID: 7173063
    [Abstract] [Full Text] [Related]

  • 17. Acute secretory diarrheas. Current concepts in pathogenesis and treatment.
    Hughes S.
    Drugs; 1983 Jul; 26(1):80-90. PubMed ID: 6349965
    [Abstract] [Full Text] [Related]

  • 18. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D, Zaremba ML, Fiedoruk K, Daniluk T, Sciepuk M, Kurzatkowska B, Sulik A, Ołdak E.
    Przegl Epidemiol; 2005 Jul; 59(3):711-21. PubMed ID: 16433313
    [Abstract] [Full Text] [Related]

  • 19. The problem of bacterial diarrhoea.
    Harries JT.
    Ciba Found Symp; 1976 Jul; (42):3-25. PubMed ID: 791597
    [Abstract] [Full Text] [Related]

  • 20. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D, Soumerai SB, Goel PK, Bates J, Makhulo J, Dondi N, Sutoto, Adi D, Ferraz-Tabor L, Hogan R.
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.